Association of plasma fibrinogen levels with coronary artery disease, smoking and inflammatory markers

Atherosclerosis

Volumn 121, Issue 2, 1996, Pages 185-191

  De Maat, Moniek P M ^a,b   Pietersma, Anneke ^a   Kofflard, Marcel ^a   Sluiter, Wim ^a   Kluft, Cornelis ^b  

^a ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

^b TNO   (Netherlands)

Author keywords

Acute phase; C reactive protein; Coronary artery disease; Fibrinogen; PTCA

Indexed keywords

C REACTIVE PROTEIN; FIBRINOGEN; INTERLEUKIN 1BETA; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ACUTE PHASE RESPONSE; ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; FEMALE; HUMAN; INFLAMMATION; MALE; PRIORITY JOURNAL; SMOKING; TRANSLUMINAL CORONARY ANGIOPLASTY;

EID: 0029983255     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/0021-9150(95)05716-1     Document Type: Article

References (31)

1. Ernst E. Plasma fibrinogen - an independent cardiovascular risk factor. J Intern Med 1990;227:365.
2. Meade TW, Brozovic M, Haines AP, Imenson JD, Mellows S, Miller GJ, North MRS, Stirling Y, Thompson SG. Haemostatic function and ischaemic heart disease: principal results of the Northwick Park Heart Study. Lancet 1986;2:533.
3. Thompson SG, Kienast J, Pyke SDM, Haverkate F, van de Loo JCW. Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. N Engl J Med 1995;332:635.
4. Naito M, Hayashi T, Kuzuya M, Funaki C, Asai K, Kuzuya F. Effects of fibrinogen and fibrin on the migration of vascular smooth muscle cells in vitro. Atherosclerosis 1990;83:9.
5. Dejana E, Languino LR, Polentarutti N, Balconi G, Ryckewaert JJ, Larrieu MJ. Interaction between fibrinogen and cultured endothelial cells. J Clin Invest 1985;75:11.
6. Leschke M, Blanke H, Styellwaag M, Motz W, Strauer BE. Hyperfibrinogenämie und pathologische Plasmaviskosität. Dtsch Med Wochensch 1988;113:1175.
7. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993;3662:801.
8. Kannel WB, Anderson K, Wilson PWF. White blood cell count and cardiovascular disease. Insights from the Framingham Study. J Am Med Assoc 1992;267:1253.
9. Nieto FJ, Szklo M, Folsom AR, Rock R, Mercuri M. Leucocyte count correlates in middle-aged adults: the atherosclerosis risk in communities (ARIC) study. Am J Epidemiol 1992;136:525.
10. Olivares R, Ducimetiere P, Claude JR. Monocyte count: a risk factor for coronary heart disease? Am J Epidemiol 1993;137:49.
11. Barath P, Fishbein MC, Cao J, Berenson J, Helfant RH, Forrester JS. Detection and localization of tumor necrosis factor in human atheroma. Am J Cardiol 1990;65:297.
12. Mazzone A, De Servi S, Ricevuti G, Mazzucchelli I, Fossati G, Pasotti D, Bramucci E, Angoli L, Marsico F, Specchia G, Notario A. Increased expression of neutrophil and monocyte adhesion molecules in unstable coronary artery disease. Circulation 1993;88:359.
13. Wal van der AC, Becker AE, Das PK. Medial thinning and atherosclerosis - evidence for involvement of a local inflammatory effect. Atherosclerosis 1993;103:55.
14. Kusher I. Regulation of the acute phase response by cytokines, Perspect Biol Med 1993;36:611.
15. Korsan-Bengtsen K, Wilhelmsen L, Tibblin G. Blood coagulation and fibrinolysis in a random sample of 788 men 54 years old. II. Relations of the variables to 'risk factors' for myocardial infarction. Thromb Diath Haemorrh 1972;28:99.
16. Ernst E. Fibrinogen, smoking and cardiovascular risk. J Smoking-Relat Dis 1993;4:37.
17. Meade TW, Imeson J, Stirling Y. Effects of changes in smoking and other characteristics on clotting factors and the risk of ischaemic heart disease. Lancet 1987;1:986.
18. Das I. Raised C-reactive protein levels in serum from smokers. Clin Chim Acta 1985;153:9.
19. Allen RA, Kluft C, Brommer EJP, Effect of chronic smoking on fibrinolysis. Arteriosclerosis 1985;5:443.
20. Holt PG. Immune and inflammatory function in cigarette smokers. Thorax 1987;42:241.
21. Yarnell JWG, Sweetnam PM, Rogers S, Elwood PC, Bainton D, Baker IA, Eastham R, O'Brien JR, Etherington MD. Some long term effects of smoking on the haemostatic system: a report from the Caerphilly and Speedwell Collaborative Surveys. J Clin Pathol 1987;40:909.
22. Kannel WB, D'Agostino RB, Belanger AJ. Fibrinogen, cigarette smoking, and risk of cardiovascular disease: insights from the Framingham Study. Am Heart J 1987;113:1006.
23. Møller L, Kristensen TS. Plasma fibrinogen and ischemic heart disease risk factors. Arteriosclerosis Thromb 1991;11:344.
24. Krobot K, Hense HW, Cremer P, Eberle E, Keil U. Determinants of plasma fibrinogen: relation to body weight, waist-to-hip ratio, smoking, alcohol, age, and sex. Arteriosclerosis Thromb 1992;12:780.
25. Cortellaro M, Boschetti C, Cofrancesco E, Zanussi C, Catalano M, de Gaetano G, Gabrielli L, Lombardi B, Specchia G, Tavazzi L, Tremoli E, Della Volpe A, Polli E, PLAT Study Group. The PLAT Study: a multidisciplinary study of hemostatic function and conventional risk factors in vascular disease patients. Atherosclerosis 1991;90:109.
26. ECAT Angina Pectoris Study: baseline associations of haemostatic factors with extent of coronary arteriosclerosis and other coronary risk factors in 3000 patients with angina pectoris undergoing coronary angiography. Eur Heart J 1993;14:8.
27. Pietersma A, Kofflard M, de Wit LEA, Stijnen T, Koster JF, Serruys PW, Sluiter W. Late lumen loss after coronary angioplasty is associated with the activation status of circulating phagocytes before treatment. Circulation 1995;91:1320.
28. Caswell M, Pike LA, Bull BS, Stuart J. Effect of patient age on tests of the acute-phase response. Arch Pathol Lab Med 1993;117:906.
29. Hoegee-De Nobel E, Voskuilen M, Briët E, Brommer EJP, Nieuwenhuizen W. A monoclonal antibody-based quantitative enzyme immunoassay for the determination of plasma fibrinogen concentrations. Thromb Haemostas 1988;60:415.
30. Hamsten A, Iseluis L, de Faire U, Blomback M. Genetic and cultural inheritance of plasma fibrinogen concentration. Lancet 1987;2:988.
31. Humphries SE, Cook M, Dubowitz M, Stirling Y, Meade TW. Role of genetic variation at the fibrinogen locus in determination of plasma fibrinogen concentrations. Lancet 1987;1:1452.